Last Updated: May 23, 2026

Claims for Patent: 9,624,298

✉ Email this page to a colleague

Summary for Patent: 9,624,298

Title:	Anti-PD-L1 antibodies and uses thereof
Abstract:	The present application relates to anti-PD-L1 antibodies or antigen binding fragments thereof, nucleic acid encoding the same, therapeutic compositions thereof, and their use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, such as tumor immunity, for the treatment of and cancer.
Inventor(s):	Horacio G. Nastri, Christel Iffland, Olivier Leger, Qi An, Mark Cartwright, Sean D. McKenna
Assignee:	Merck Patent GmbH
Application Number:	US14/360,775

Details for Patent 9,624,298

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Emd Serono, Inc.	BAVENCIO	avelumab	Injection	761049	March 23, 2017	⤷ Start Trial	2032-11-21
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,624,298

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	201404790	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2013079174	⤷ Start Trial
United States of America	2021054073	⤷ Start Trial
United States of America	2017253654	⤷ Start Trial
United States of America	2017253653	⤷ Start Trial
United States of America	2014341917	⤷ Start Trial
United States of America	11884724	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.